8 24 Week treatment regimen with peginterferon alpha-2a (40KD) (PEGASYS®) plus ribavirin (COPEGUS®) in HCV genotype 1 or 4 ‘super-responders’
- 30 April 2006
- journal article
- abstracts
- Published by Elsevier in Journal of Hepatology
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: